Eszter Szabados

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Bariatric Surgery

Top Venues

International journal of molecular sciences

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Zsolt Szekeres, Andras Nagy, Kamilla Jahner, Eszter Szabados
Impact of Selected Glucagon-like Peptide-1 Receptor Agonists on Serum Lipids, Adipose Tissue, and Muscle Metabolism-A Narrative Review. International journal of molecular sciences 25 (15) (2024)
Zsolt Szekeres, Andras Nagy, Kamilla Jahner, Eszter Szabados
Impact of Selected Glucagon-like Peptide-1 Receptor Agonists on Serum Lipids, Adipose Tissue, and Muscle Metabolism-A Narrative Review. International journal of molecular sciences 25 (15) (2024)
Zsolt Szekeres, Barbara Sandor, Zita Bognar, Fadi H J Ramadan, Anita Palfi, Beata Bodis, Kalman Toth, Eszter Szabados
Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes. International journal of molecular sciences 24 (5) (2023)
Zsolt Szekeres, Barbara Sandor, Zita Bognar, Fadi H J Ramadan, Anita Palfi, Beata Bodis, Kalman Toth, Eszter Szabados
Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes. International journal of molecular sciences 24 (5) (2023)
Zsolt Szekeres, Barbara Sandor, Zita Bognar, Fadi H J Ramadan, Anita Palfi, Beata Bodis, Kalman Toth, Eszter Szabados
Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes. International journal of molecular sciences 24 (5) (2023)
Adam Riba, Laszlo Deres, Balazs Sumegi, Kalman Toth, Eszter Szabados, Robert Halmosi
Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model. Oxidative medicine and cellular longevity 2017 (2017)